In reply to: Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer
Publication date: Available online 21 February 2017 Source:European Journal of Surgical Oncology (EJSO) Author(s): Icro Meattini, Giulio Francolini, Lorenzo Livi, Jacopo Nori
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου